The chapter summarizes the studies that evaluated medicine prices in Asia–Pacific countries. The primary aim of this review was to report medicine prices in Asia–Pacific region in the last decade and document their significant findings. Almost all included studies have employed World Health Organization/Health Action International methodology to report medicine prices data. The included studies focused on the prices of cancer medicines, central nervous system–related disorders, hepatitis C, and essential medicines for chronic conditions. Affordability is particularly reviewed with medicine prices with a focus on generic medicines for cost savings. Finally, the challenges in formulating medicine pricing policy in Asia–Pacific region are discussed.
|Title of host publication||Medicine Price Surveys, Analyses and Comparisons|
|Subtitle of host publication||Evidence and Methodology Guidance|
|Number of pages||16|
|Publication status||Published - 2019|
Babar, Z-U-D., Hussain, R., & Hasan, S. S. (2019). Medicine Prices in Asia–Pacific Countries. In S. Vogler (Ed.), Medicine Price Surveys, Analyses and Comparisons: Evidence and Methodology Guidance (1st ed., pp. 45-60). Elsevier. https://doi.org/10.1016/B978-0-12-813166-4.00005-X